Skip to content

RVPH REVIVA PHARMACEUTCLS HLDGS I

Follow

COM NEW (common), issuer CIK 1742927

5 managers (5 13F filers) reported a position in RVPH shares at 2026-06-30, 7,728 shares in all. 2 filers opened a position and 33 filers sold out during the quarter.

Managers
5
13F filers
5
New
2
Added
0
Reduced
0
Sold out
33
Shares held by filers
7,728

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q2 2026

Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
EMC Capital Management6,696$3K<0.01%13F-HRTimeline
TD Waterhouse Canada Inc.625$412<0.01%013F-HRTimeline
Purpose Unlimited Inc.in group Purpose Unlimited Inc.405$259<0.01%013F-HRTimelineGroup
Mosley Wealth Management1$1<0.01%new13F-HRTimeline
Miller Global Investments, LLC1$1<0.01%new13F-HRTimeline